SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-064391
Filing Date
2024-03-11
Accepted
2024-03-11 08:44:48
Documents
2
Group Members
JAMES HUANGPANACEA VENTURE HEALTHCARE FUND II GP CO LTDPANACEA VENTURE HEALTHCARE FUND II L.P

Document Format Files

Seq Description Document Type Size
1 SC 13G d745577dsc13g.htm SC 13G 87926
2 EX-99 d745577dex99.htm EX-99 6449
  Complete submission text file 0001193125-24-064391.txt   96131
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Subject) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93265 | Film No.: 24736678
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PANACEA VENTURE, NO. 5, LANE 1350 FUXING MIDDLE ROAD SHANGHAI F4 200031
Business Address C/O PANACEA VENTURE, NO. 5, LANE 1350 FUXING MIDDLE ROAD SHANGHAI F4 200031 86 21 60252100
Panacea Innovation Ltd (Filed by) CIK: 0002010692 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G